Bevacizumab and central nervous system (CNS) hemorrhage

Cancer Chemotherapy and Pharmacology

Volumn 71, Issue 6, 2013, Pages 1561-1565

  Letarte, Nathalie ^a   Bressler, Linda R ^b   Villano, John L ^c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Adverse event; Anti angiogenesis; Bevacizumab; Cerebral hemorrhage; CNS hemorrhage

Indexed keywords

BEVACIZUMAB; HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN;

ADULT; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BRAIN METASTASIS; BREAST CANCER; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM HEMORRHAGE; CENTRAL NERVOUS SYSTEM METASTASIS; COLORECTAL CANCER; CONTROLLED STUDY; DEATH; DRUG EFFICACY; FEMALE; GLIOMA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STOMACH CANCER; SUBARACHNOID HEMORRHAGE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DATABASES, FACTUAL; HUMANS; INTRACRANIAL HEMORRHAGES; NEOPLASMS; RISK FACTORS;

EID: 84878660826     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-013-2155-4     Document Type: Article

References (17)

1. Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342
2. Sandler A, Gray R, Perry MC et al (2006) Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355:2542-2550
3. Escudier B, Pluzanska A, Koralewski P et al (2007) Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Lancet 370:2103-2111
4. Friedman HS, Prados MD, Wen PY et al (2009) Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27:4733-4740
5. Johnson DH, Fehrenbacher L, Novotny WF et al (2004) Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 22:2184-2191
6. Gordon MS, Margolin K, Talpaz M et al (2001) Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer. J Clin Oncol 19:843-850
7. Besse B, Lasserre SF, Compton P et al (2010) Bevacizumab safety in patients with central nervous system metastases. Clin Cancer Res 16:269-278
8. Socinski MA, Langer CJ, Huang JE et al (2009) Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases. J Clin Oncol 27:5255-5261
9. Labidi SI, Bachelot T, Ray-Coquard I et al (2009) Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case series. Clin Breast Cancer 9:118-121
10. Carden CP, Larkin JM, Rosenthal MA (2008) What is the risk of intracranial bleeding during anti-VEGF therapy? Neuro Oncol 10:624-630
11. Bevacizumab prescribing information. In: Genentech Inc. San Francisco, CA. Available from http://www.gene.com/gene/products/information/pdf/avastin- prescribing.pdf. Accessed 2 July 2012
12. Khasraw M, Holodny A, Goldlust SA, DeAngelis LM (2012) Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience. Ann Oncol 23:458-463
13. Chen HX, Mooney M, Boron M et al (2006) Phase II multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI Treatment Referral Center Trial TRC-0301. J Clin Oncol 24:3354-3360
14. Giantonio BJ, Catalano PJ, Meropol NJ et al (2007) Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 25:1539-1544
15. Nguyen TD, Abrey LE (2007) Intracranial hemorrhage in patients treated with bevacizumab and low-molecular weight heparin. Clin Adv Hematol Oncol 5:375-376 Discussion 377-379
16. Nishimura T, Furihata M, Kubo H et al (2011) Intracranial hemorrhage in patients treated with bevacizumab: report of two cases. World J Gastroenterol 17:4440-4444
17. Tanvetyanon T, Murtagh R, Bepler G (2009) Rupture of a cerebral arteriovenous malformation in a patient treated with bevacizumab. J Thorac Oncol 4:268-269